49.1 Clinical Features
• Multinodular, simple (smoothly enlarged), retrosternal goitres
• Increased where iodine is deficient
• Long-standing may develop clinical or subclinical thyrotoxicosis
• Symptoms
Neck swelling
Dyspnea
Dysphagia
Choking
Stridor
49.2 Epidemiology
• Ethnicity
No racial predilection exists
• Incidence
Multinodular goitres is one of the common endocrine conditions, affecting 500 million people worldwide
• Sex
F:M 5:1
In the Wickham study, 26% of women had a goitre compared with 7% of men
Thyroid nodules are less frequent in men than in women, but when found, they are more likely to be malignant
• Age
The frequency of goitres decreases with advancing age
The decrease in frequency differs from the incidence of thyroid nodules, which increases with advancing age
• Aetiology
Iodine deficiency
Autoimmune thyroiditis—Hashimoto or postpartum thyroiditis
Excess iodine (Wolff–Chaikoff effect) or lithium ingestion, which decrease release of thyroid hormone
Goitrogens, e.g., propylthiouracil, lithium, carbamazepine
Stimulation of thyroid stimulating hormone (TSH) receptors by TSH from pituitary tumours, pituitary thyroid hormone resistance, gonadotropins, and/or thyroid-stimulating immunoglobulins
Inborn errors of metabolism causing defects in biosynthesis of thyroid hormones
Exposure to radiation
Deposition diseases
Thyroid hormone resistance
Subacute thyroiditis (de Quervain thyroiditis)
Silent thyroiditis
Riedel thyroiditis
Infectious agents
– Acute suppurative—bacterial
– Chronic—mycobacteria, fungal, and parasitic
Granulomatous disease
Thyroid malignancy
49.3 Simple Goitres (Fig. 49.1)
• Physiological
Puberty
Pregnancy
oral contraceptive pill (OCP)
• Pathological—iodine deficiency
• Medical treatments
Radioactive iodine:
– Up to 50% reduction in goitre volume
– Risks include: hypothyroidism, Graves
– Contraindicated in pregnant women or women wanting to get pregnant within 1 year of treatment
Suppression therapy:
– Thyroxine administration decreases TSH leading to a reduction in volume
– Risks include: thyrotoxicosis, cardiac arrythmias, thyroid increases to pretreatment size on cessation of thyroxine, osteopenia in long-term thyroxine use
Antithyroid medication:
– Indicated for thyrotoxic patients, e.g., propylthiouracil (side effects: rash and agranulocytosis)
– 50% relapse rate
• Retrosternal goitre
May present with dyspnea, stridor that is positional/nocturnal, or coincidentally on chest X-ray with shadowing in upper mediastinum
– Inability to palpate below it
– Dullness to percussion over sternum
– May only be a small cervical component
– Pemberton sign: facial flushing after raising both arms in the air due to compression of jugular veins by thyroid
Investigations:
– CT scan good for demonstrating retrosternal extent ± tracheal compression
– Spirometry
Treatment:
– Conservative (if medically unfit)
– Surgery: most can be removed via cervical route (unless below aortic arch) may need cardiothoracic input ± sternotomy
– Increasing role of radioactive iodine in euthyroid retrosternal goitre safe to use down to a tracheal diameter of 1 cm
49.3.1 Toxic Goitres
49.3.2 Clinical Features
• Graves disease
Most common
One or more:
– Thyrotoxicosis
– Goitre
– Eye signs: lid lag, exophthalmos, chemosis
– Skin signs: acropachy, pretibial myxedema
Autoimmune with thyroid antibodies
15% family history
F>M 5:1; middle ages
Treatments:
– Radioactive iodine
– Antithyroid drugs, e.g., carbimazole or propylthiouracil
– Block and replace: antithyroid drugs full dose + thyroxine to replace thyroid function
– Surgery
• Solitary toxic nodule
• Long-standing MNGs (Plummer disease)
49.3.3 Treatment
• 50% of patients relapse on carbimazole/propylthiouracil—may request thyroidectomy
• When considering surgery need to achieve euthyroid state preop with antithyroid medication, β-blockade and Lugol iodine (up to 2 weeks preop)

Full access? Get Clinical Tree

